These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents. Manouchehrizadeh E, Mostoufi A, Tahanpesar E, Fereidoonnezhad M. Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562 [Abstract] [Full Text] [Related]
11. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches. Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH. Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746 [Abstract] [Full Text] [Related]
12. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease. El Khatabi K, El-Mernissi R, Aanouz I, Ajana MA, Lakhlifi T, Khan A, Wei DQ, Bouachrine M. J Mol Model; 2021 Sep 28; 27(10):302. PubMed ID: 34581863 [Abstract] [Full Text] [Related]
13. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques. Abdizadeh R, Hadizadeh F, Abdizadeh T. Med Chem; 2020 Sep 28; 16(7):903-927. PubMed ID: 31385775 [Abstract] [Full Text] [Related]
15. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues. Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M, Cavrini V. J Med Chem; 2000 May 18; 43(10):2007-18. PubMed ID: 10821713 [Abstract] [Full Text] [Related]